Literature DB >> 31791872

The effect of HIV infection and exposure on cognitive development in the first two years of life in Malawi.

Thomas Struyf1, Queen Dube2, Elizabeth A Cromwell3, Anna D Sheahan4, Robert S Heyderman5, Annelies Van Rie6.   

Abstract

OBJECTIVES: To assess longitudinal patterns and determinants of cognitive development in infants living with HIV, infants exposed to maternal HIV infection, and HIV-unexposed infants.
METHODS: Prospective, community-based cohort study of 555 Malawian infants aged 8 weeks to 24 months, using multivariable linear mixed-effects regression models with random intercepts to analyze repeated measures of cognitive function.
RESULTS: At 3 months of age, cognitive scores on the Bayley Scales of Infant Development (BSID 3rd edition) were lower in the 96 HIV-infected infants (mean = 14.1 (SD:4.8)) compared to the 289 HIV-exposed (mean = 16.5 (SD:3.7)) and the 170 unexposed infants (mean = 17.5 (SD:3.3)). Over the first two years of life, the small deficit in cognitive development of infants living with HIV who survived and remained in care did not increase (mean score 52.9 among HIV-infected vs 55.6 among HIV unexposed). In multivariable analysis, malnutrition and a more advanced clinical infant HIV stage had a negative impact on cognition at age 3, while financial security, care by the biological mother, and ART for mother and child were associated with better cognitive status at this young age. The positive influence of maternal ART reversed with age.
CONCLUSIONS: Malawian infants exposed to HIV had a cognitive development that was similar to their unexposed peers in the first two years of life, while that of HIV infected infants lagged behind from the start. Early initiation of effective ART in all HIV infected mothers and infants, and prevention of infant malnutrition are important to safeguard cognitive development of children affected by HIV.
Copyright © 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; Africa; Cognitive development; HIV; Infants

Mesh:

Year:  2019        PMID: 31791872      PMCID: PMC7136137          DOI: 10.1016/j.ejpn.2019.11.004

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  48 in total

Review 1.  Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

2.  Neurologic manifestations of human immunodeficiency virus infection in children.

Authors:  L G Epstein; L R Sharer; J M Oleske; E M Connor; J Goudsmit; L Bagdon; M Robert-Guroff; M R Koenigsberger
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

3.  Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo.

Authors:  Annelies Van Rie; Anna Dow; Aimee Mupuala; Paul Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

4.  Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group.

Authors:  C Chase; J Ware; J Hittelman; I Blasini; R Smith; A Llorente; E Anisfeld; C Diaz; M G Fowler; J Moye; L I Kaligh
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

5.  Brief report: effects of pediatric HIV infection on mental and psychomotor development.

Authors:  W G Knight; C A Mellins; R L Levenson; S M Arpadi; R Kairam
Journal:  J Pediatr Psychol       Date:  2000-12

6.  Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.

Authors:  Sara E Forhan; Surbhi Modi; James C Houston; Laura N Broyles
Journal:  AIDS       Date:  2017-06-19       Impact factor: 4.177

7.  Early neurodevelopmental markers predictive of mortality in infants infected with HIV-1.

Authors:  Antolin Llorente; Pim Brouwers; Manhattan Charurat; Laurence Magder; Kathleen Malee; Claude Mellins; Janice Ware; Joan Hittleman; Lynne Mofenson; Jesus Velez-Borras; Samuel Adeniyi-Jones
Journal:  Dev Med Child Neurol       Date:  2003-02       Impact factor: 5.449

8.  Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Authors:  Patricia A Sirois; Yanling Huo; Paige L Williams; Kathleen Malee; Patricia A Garvie; Betsy Kammerer; Kenneth Rich; Russell B Van Dyke; Molly L Nozyce
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

Review 9.  Treatment of perinatal viral infections to improve neurologic outcomes.

Authors:  William J Muller
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

10.  Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.

Authors:  Sarah Benki-Nugent; Dalton Wamalwa; Agnes Langat; Kenneth Tapia; Judith Adhiambo; Daisy Chebet; Helen Moraa Okinyi; Grace John-Stewart
Journal:  BMC Pediatr       Date:  2017-01-17       Impact factor: 2.125

View more
  3 in total

Review 1.  Neuroimmunology of CNS HIV Infection: A Narrative Review.

Authors:  Ana-Claire Meyer; Alfred Kongnyu Njamnshi; Magnus Gisslen; Richard W Price
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Catherine J Wedderburn; Ella Weldon; Cesc Bertran-Cobo; Andrea M Rehman; Dan J Stein; Diana M Gibb; Shunmay Yeung; Andrew J Prendergast; Kirsten A Donald
Journal:  Lancet Child Adolesc Health       Date:  2022-04-26

3.  Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa.

Authors:  Hlengiwe P Madlala; Landon Myer; Thokozile R Malaba; Marie-Louise Newell
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.